GlaxoSmithKline brand to be featured on Target Indy car
INDIANAPOLIS Chip Ganassi Racing on Wednesday announced that GlaxoSmithKline’s Breathe Right brand will be placed on the nose of the team’s Target Indy car this weekend during the Peak Antifreeze and Motor Oil Indy 300 Chicagoland Speedway races.
Additionally, on Aug. 28, race fans will have the opportunity to meet two-time and reigning IZOD IndyCar Series champion Dario Franchitti, driver of the Target Indy car, on-site at the Breathe Right Advanced tent where free product samples will be made available.
“Putting on my nasal strip is part of my ritual when suiting up for every race as I need it to breathe better so I am ready to operate at 100%,” Franchitti stated. “However, you don’t need to be a professional driver to understand the importance of being at your best. Breathe Right nasal strips can help you breathe better so you can get a good night’s sleep.”
GlaxoSmithKline will tout its latest Breathe Right product introduction, Breathe Right Advanced, at the race. The newly patented strip has a unique design allowing for four points of contact to increase airflow and help open nasal passages more completely.
LiceGuard makes appearance in ‘The Switch’
NEEDHAM, Mass. ARR Health Technologies scored a product placement for its LiceGuard products in the movie “The Switch,” starring Jennifer Aniston and Jason Bateman, which debuted Friday.
“The Switch” grossed $8.1 million at the box office over the weekend.
In the movie, Jason Bateman’s character is shown choosing LiceGuard SAFE lice egg remover shampoo to treat his child. There are several scenes where the product’s distinctive yellow cap can be seen, the company stated in a press released issued Tuesday.
“We are very pleased that the RobiComb and our SAFE lice remover shampoo were used in the movie ‘The Switch,'” stated Mark Stearns, VP business development for ARR Health Technologies. “It was important to the actors to show parents using a nontoxic lice treatment, and we are glad that LiceGuard was chosen from all the available options.”
Perrigo gets FDA approval to manufacture milk-based infant formulas
ALLEGAN, Mich. The Food and Drug Administration has given Perrigo the go-ahead to manufacture milk-based infant formulas through its partner, Saint-Claire, Quebec-based Kerry Proteins and Nutritionals, Perrigo said Wednesday.
The company received FDA clearance to market milk-based, ready-to-use and concentrate infant formulas with ARA and DHA in 8-oz. and 13-oz. bottles, and milk-based organic infant formula in 8-oz. bottles.
“We are excited to receive FDA clearance on these new liquid concentrate and ready-to-use products, and to expand our portfolio of nonpowder infant formula products,” Perrigo chairman and CEO Joseph Papa stated. “This is the first launch of new products since acquiring our infant nutrition business, and we look forward to further new product introductions.”